A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Public ClinicalTrials.gov record NCT01278173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Study identification
- NCT ID
- NCT01278173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Lundbeck LLC
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Sabril Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Apr 30, 2015
- Completion
- Apr 30, 2015
- Last update posted
- Jun 6, 2016
2010 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 18
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| Yale Medical Center | New Haven | Connecticut | 06520 | — |
| CNMRI | Dover | Delaware | 19901 | — |
| Sunrise Clinical Research Group | Hollywood | Florida | 33021-2834 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Peachtree Neurological Clinic | Atlanta | Georgia | 30309 | — |
| Idaho Comprehensive Epilepsy Center | Boise | Idaho | 83702 | — |
| OSF Saint Francis Medical Center | Peoria | Illinois | 61637 | — |
| University of Kentucky Lexington | Lexington | Kentucky | 40536 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Minnesota Epilepsy Group, PA | Saint Paul | Minnesota | 55102 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Columbia University Medical Center | New York | New York | 10087 | — |
| Neuroscience & Spine Institute | Charlotte | North Carolina | 28207 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas | Houston | Texas | 77030 | — |
| Covenant Medical Group | Lubbock | Texas | 79410 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
| Aurora BayCare Medical Center | Green Bay | Wisconsin | 54308 | — |
| Aurora St. Luke's Medical Center | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01278173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 6, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01278173 live on ClinicalTrials.gov.